Evaluation of Assays for Antibody to Hepatitis E Virus by a Serum Panel

References

1. Balayan MS, Andjaparidze AG, Savinskaya SS, Ketiladze ES, Braginsky DM, Savinov AP, Poleschuk VF. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983; 20: 23-31[ [ Link previously at www.ncbi.nlm.nih.gov ]].

2. Kane MA, Bradley DW, Shrestha SM, Maynard JE, Cood EH, Mishra PP, Joshi DD. Epidemic non-A, non-B hepatitis in Nepal: recovery of a possible etiologic agent and transmission studies in marmosets. JAMA 1984; 252: 3140-3145[ [ Link previously at www.ncbi.nlm.nih.gov ]].

3. Krawczynski K, Bradley DW. Enterically transmitted non-A, non-B hepatitis: identification of virus-associated antigen in experimentally infected cynomolgus macaques. J Infect Dis 1989; 159: 1042-1049[ Medline].

4. Purdy MA, Carson D, McCaustland KA, Bradley DW, Beach MJ, Krawczynski K. Viral specificity of hepatitis E virus antigens identified by fluorescent antibody assay using recombinant HEV proteins. J Med Virol 1994; 44: 212-214[ [ Link previously at www.ncbi.nlm.nih.gov ]].

5. Purdy MA, McCaustland KA Krawczynski K, Tam A, Beach MJ, Tassopoulos NC, et al. Expression of a hepatitis E virus (HEV)-trpE fusion protein containing epitopes recognized by antibodies in sera from human cases and experimentally infected primates. Arch Virol 1992;123:335-349.

6. Favorov MO, Fields HA, Purdy MA, Yashina TL, Aleksandrov AG, Alter MJ, et al. Serologic identification of hepatitis E virus infections i n epidemic and endemic settings. J Med Virol 1992; 36: 246-250[ [ Link previously at www.ncbi.nlm.nih.gov ]].

7. Dawson GJ, Chau KH, Cabal CM, Yarbough PO, Reyes GR, Mushahwar IK. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J Virol Methods 1992; 38: 175-186[ [ Link previously at www.ncbi.nlm.nih.gov ]].

8. Tsarev SA, Tsareva TS, Emerson SU, Kapikian AZ, Ticehurst J, London W, Purcell RH. ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infect Dis 1993; 168: 369-378[ [ Link previously at www.ncbi.nlm.nih.gov ]].

9. Uchida T, Aye TT, Ma X, Iida F, Shikata T, Ichikawa M, et al. An epidemic of hepatitis E in Yangon of Myanmar: antibody assay and animal transmission of the virus. Acta Pathol Jpn 1993; 43: 94-98[ [ Link previously at www.ncbi.nlm.nih.gov ]].

10. Favorov MO, Khudyakov YE, Fields HA, Khudyakova NS, Padhye N, Alter MJ, et al. Enzyme immunoassay for the detection of antibody to hepatitis E virus based on synthetic peptides. J Virol Methods 1994; 46: 237-250[ [ Link previously at www.ncbi.nlm.nih.gov ]].

11. Li F, Zhuang H, Kolivas S, Locarnini SA, Anderson DA. Persistent and transient antibody responses to hepatitis E virus detected by western immunoblot using open reading frame 2 and 3 and glutathione S-transferase fusion proteins. J Clin Microbiol 1994; 32: 2060-2066[ Abstract].

12. Yarbough PO, Tam AW, Gabor K, Garza E, Moeckli RA, Palings I, et al. Assay development of diagnostic tests for hepatitis E. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral hepatitis and liver disease, Tokyo: Springer-Verlag, 1994:367-370.

13. Coursaget P, Depril N, Buisson Y, Molinie C, Roue R. Hepatitis type E in a French population: detection of anti-HEV by a synthetic peptide-based enzyme-linked immunosorbent assay. Res Virol 1994; 145: 51-57[ [ Link previously at www.ncbi.nlm.nih.gov ]].

14. Nanda SK, Ansari IH, Acharya SK, Jameel S, Panda SK. Protracted viremia during acute sporadic hepatitis E virus infection. Gastroenterology 1995; 108: 225-230[Abstract].

15. Favorov MO, Khudyakov YE, Mast EE, Yashina TL, Shapiro CN, Khudyakova NS, et al. IgM and IgG antibody to hepatitis E virus (HEV) detected by enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein. J Med Virol 1996; 50: 50-58[ [ Link previously at www.ncbi.nlm.nih.gov ]].

16. Panda SK, Nanda SK, Zafrullah M, Ansari I, Ozdener MH, Jameel S. An Indian strain of hepatitis E virus (HEV): cloning, sequence, and expression of structural region and antibody responses in sera from individuals from an area of high-level HEV endemicity. J Clin Microbiol 1995; 33: 2653-2659[ Abstract].

17. Bryan JP, Tsarev SA, Iqbal M, Ticehurst J, Emerson S, Ahmed A, et al. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis 1994; 170: 517-521[ [ Link previously at www.ncbi.nlm.nih.gov ]].

18. Heath TC, Burrow JN, Currie BJ, Bowden FJ, Fisher DA, Demediuk BH, et al. Locally acquired hepatitis E in the Northern Territory of Australia. Med J Aust 1995; 162: 318-319[ [ Link previously at www.ncbi.nlm.nih.gov ]].

19. Zanetti AR, Dawson GJ. Hepatitis type E in Italy: a seroepidemiological survey. J Med Virol 1994; 42: 318-320[ [ Link previously at www.ncbi.nlm.nih.gov ]].

20. Coursaget P, Depril N, Buisson Y, Molinie C, Roue R. Hepatitis E in a French population: detection of anti-HEV by a synthetic peptide-based enzyme-linked immunosorbent assay. Res Virology 1994; 145: 51-57[ [ Link previously at www.ncbi.nlm.nih.gov ]].

21. Tassopoulos NC, Krawczynski K, Hatzakis A, Katsoulidou A, Delladetsima I, Koutelou MG, Trichopoulos D. Case report: role of hepatitis E virus in the etiology of community-acquired non-A, non-B hepatitis in Greece. J Med Virol 1994; 42: 124-128[ [ Link previously at www.ncbi.nlm.nih.gov ]].

22. Sallie R, Silva AE, Purdy M, Smith H, McCaustland K, Tibbs C, et al. Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serologic study. J Hepatol 1994; 20: 580-588[ [ Link previously at www.ncbi.nlm.nih.gov ]].

23. Zaaijer HL, Kok M, Lelie PN, Timmerman RJ, Chau K, van der Pal HJH. Hepatitis E in the Netherlands: imported and endemic. Lancet 1993; 341: 826[ [ Link previously at www.ncbi.nlm.nih.gov ]].

24. Mast EE, Kuramoto IK, Favorov MO, Schoenig VR, Burkholder BT, Shapiro CN, Holland PV. Prevalence and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California. J Infect Dis 1997; 176: 34-40[ [ Link previously at www.ncbi.nlm.nih.gov ]]

25.Paul DA, Knigge MF, Ritter A, Gutierrez R, Pilot-Matiias T, Chau KH, Dawson GW. Determination of hepatitis E virus seroprevalence by using recombinant fusion proteins and synthetic peptides. J Infect Dis 1994; 169: 801-806[ [ Link previously at www.ncbi.nlm.nih.gov ]].

26. Zanetti AR, Dawson GJ, the Study Group of Hepatitis E. Hepatitis type E in Italy: a seroepidemiological survey. J Med Virol 1994; 42: 318-320[ [ Link previously at www.ncbi.nlm.nih.gov ]].

27. Thomas DL, Yarbough PO, Vlahov D, Tsareva SA, Nelson KE, Saah AJ, Purcell RH. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 1997; 35: 1244-1247[ Abstract].

28. Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, Reyes GR. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991; 185: 120-131[ Medline].

29. Huang CC, Nguyen D, Fernandez J, Yun KY, Fry KE, Bradley DW, et al. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology 1992; 191: 550-558[ [ Link previously at www.ncbi.nlm.nih.gov ]].

30. Tsarev SA, Emerson SU, Reyes GR, Tsareva TS, Letgers LJ, Malik IA, et al. Characterization of a prototype strain of hepatitis E virus. Proc Natl Acad Sci U S A 1992; 89: 559-563[ [ Link previously at www.ncbi.nlm.nih.gov ]].

31. Aye TT, Uchida T, Ma XZ, Iida F, Shikata T, Zhuang H, Win KM. Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986-1988) of China. Nucleic Acids Res 1992; 20: 3512[ [ Link previously at www.ncbi.nlm.nih.gov ]].

32. Bradley DW, Andjaparidze A, Cook EH, McCaustland K, Balayan M, Stetler H, et al. Aetiological agent of enterically transmitted non-A, non-B hepatitis. J Gen Virol 1988; 69: 731-738[ [ Link previously at www.ncbi.nlm.nih.gov ]].

33. Krawczynski K. Antigens and antibodies of hepatitis E virus infection in experimental primate models and man. In: Hollinger FB, Lemon SM, Margolis HS, eds. Viral hepatitis and liver disease, Baltimore: Williams & Wilkins, 1991:517-521.

34. Meng XJ, Purcell RH, Halbur PG, Lehman JR, Webb DM, Tsareva TS, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A 1997; 94: 9860-9865[ Abstract/Full Text].

Return To Article